IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-18728 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

In Vitro Diagnostic (IVD) Reagents Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET

7.1 GLOBAL IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTIC (IVD) REAGENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Merck KGaA

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Becton, Dickinson and Company

16.3 Thermo Fisher Scientific

16.4 Bio-Rad Laboratories, Inc.

16.5 Drgerwerk AG

16.6 LGC Biosearch Technologies

16.7 BioLegend, Inc.

16.8 InBios International, Inc

16.9 LakePharma, Inc.

16.10 Bioline

16.11 Abcam plc

16.12 The Binding Site Group Ltd.

16.13 SDIX, LLC

16.14 Bio-Techne Corporation

16.15 Agilent Technologies, Inc.

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Antibodies
  o Type
     o Monoclonal
     o Polyclonal
  o Target
     o CD
     o TCR
     o EGFR
Oligonucleotides
Nucleic Acid Probes
Purified Proteins or Peptides

By Technology
Immunoassay/Immunochemistry
  o Enzyme Linked Immunosorbent Assays (ELISA)
  o Western Blotting
  o Immunofluorescence
  o Immunohistochemistry
  o Functional Assays
  o Immunoprecipitation
Biochemistry/Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation/Hemostatis
Urinalysis

By End Use
IVD Manufacturers
Reference Laboratories
Academic and Research Institutes
Hospital Laboratories

Companies

Merck KGaA
Becton, Dickinson and Company
Thermo Fisher Scientific
Bio-Rad Laboratories, Inc.
Drgerwerk AG
LGC Biosearch Technologies
BioLegend, Inc.
InBios International, Inc
LakePharma, Inc.
Bioline
Abcam plc
The Binding Site Group Ltd.
SDIX, LLC
Bio-Techne Corporation
Agilent Technologies, Inc.

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.